← UNITEDHEALTH GROUP INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Accounts receivable, net of allowances of $1,208 and $985 | $8.2b | $9.6b | $11.4b | $11.8b | $12.9b | $14.2b | $17.7b | $21.3b | $22.4b | $23.0b | |
| Cash and Cash Equivalents, at Carrying Value | $10.4b | $12.0b | $10.9b | $11.0b | $16.9b | $21.4b | $23.4b | $25.4b | $25.3b | $24.4b | |
| Cash and cash equivalents | $10.4b | $12.0b | $10.9b | $11.0b | $16.9b | $21.4b | $23.4b | $25.4b | $25.3b | $24.4b | |
| Prepaid Expense and Other Assets, Current | $1.8b | $2.7b | $3.1b | $3.9b | $4.5b | $5.3b | $6.6b | $6.1b | $8.2b | $9.7b | |
| Prepaid expenses and other current assets | $1.8b | $2.7b | $3.1b | $3.9b | $4.5b | $5.3b | $6.6b | $6.1b | $8.2b | $9.7b | |
| Short-term Investments | $2.8b | $3.5b | $3.5b | $3.3b | $2.9b | $2.5b | $4.5b | $4.2b | $3.8b | $3.8b | |
| Inventory, Net | — | — | — | — | — | — | $3.5b | $2.8b | $3.8b | $3.3b | |
| Assets, Current | $33.9b | $37.1b | $38.7b | $42.6b | $53.7b | $61.8b | $69.1b | $78.4b | $85.8b | $90.6b | |
| Total current assets | $33.9b | $37.1b | $38.7b | $42.6b | $53.7b | $61.8b | $69.1b | $78.4b | $85.8b | $90.6b | |
| Long-term investments | $23.9b | $28.3b | $32.5b | $37.2b | $41.2b | $43.1b | $43.7b | $47.6b | $52.4b | $54.3b | |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $7,546 and $6,971 | $5.9b | $7.0b | $8.5b | $8.7b | $8.6b | $9.0b | $10.1b | $11.4b | $10.6b | $10.8b | |
| Property, Plant and Equipment, Net | $5.9b | $7.0b | $8.5b | $8.7b | $8.6b | $9.0b | $10.1b | $11.4b | $10.6b | $10.8b | |
| Goodwill | $47.6b | $54.6b | $58.9b | $65.7b | $71.3b | $75.8b | $93.4b | $103.7b | $106.7b | $110.5b | |
| Intangible Assets, Net (Excluding Goodwill) | $8.5b | $8.5b | $9.3b | $10.3b | $10.9b | $10.0b | $14.4b | $15.2b | $23.3b | $20.5b | |
| Other intangible assets, net of accumulated amortization of $7,472 and $8,350 | $8.5b | $8.5b | $9.3b | $10.3b | $10.9b | $10.0b | $14.4b | $15.2b | $23.3b | $20.5b | |
| Other Assets, Noncurrent | $3.0b | $3.6b | $4.3b | $9.3b | $11.5b | $12.5b | $15.0b | $17.3b | $19.6b | $23.0b | |
| Other assets | $3.0b | $3.6b | $4.3b | $9.3b | $11.5b | $12.5b | $15.0b | $17.3b | $19.6b | $23.0b | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $8.2b | $9.6b | $11.4b | $11.8b | $12.9b | $14.2b | $17.7b | $21.3b | $22.4b | $23.0b | |
| Deferred income taxes | $2.8b | $2.2b | $2.5b | $3.0b | $3.4b | $3.3b | $2.8b | $3.0b | $3.6b | $2.4b | |
| Medical costs payable | $16.4b | $17.9b | $19.9b | $21.7b | $21.9b | $24.5b | $29.1b | $32.4b | $34.2b | $39.3b | |
| Other current liabilities | $10.3b | $12.3b | $12.2b | $14.6b | $20.4b | $23.0b | $26.3b | $27.1b | $27.3b | $28.0b | |
| Other current receivables, net of allowances of $3,763 and $2,864 | $7.5b | $6.3b | $6.9b | $9.6b | $12.5b | $13.9b | $12.8b | $17.7b | $26.1b | $29.7b | |
| Other liabilities | $2.3b | $5.6b | $5.7b | $10.1b | $12.3b | $11.8b | $12.8b | $14.5b | $15.9b | $18.2b | |
| Total equity | $38.2b | $49.8b | $54.3b | $60.4b | $68.3b | $75.0b | $81.5b | $94.4b | $98.3b | $100.1b | |
| Assets | $122.8b | $139.1b | $152.2b | $173.9b | $197.3b | $212.2b | $245.7b | $273.7b | $298.3b | $309.6b | |
| Total assets | $122.8b | $139.1b | $152.2b | $173.9b | $197.3b | $212.2b | $245.7b | $273.7b | $298.3b | $309.6b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued liabilities | $13.4b | $15.2b | $16.7b | $19.0b | $22.5b | $24.6b | $27.7b | $32.0b | $34.3b | $38.0b | |
| Deferred Revenue, Current | $2.0b | $2.3b | $2.4b | $2.6b | $2.8b | $2.6b | $3.1b | $3.4b | $3.3b | $3.4b | |
| Long-term Debt, Current Maturities | $7.2b | $2.9b | $2.0b | $3.9b | $4.8b | $3.6b | $3.1b | $4.3b | $4.5b | $6.1b | |
| Long-term Debt, Excluding Current Maturities | $25.8b | $28.8b | $34.6b | $36.8b | $38.6b | $42.4b | $54.5b | $58.3b | $72.4b | $72.3b | |
| Long-term debt, less current maturities | $25.8b | $28.8b | $34.6b | $36.8b | $38.6b | $42.4b | $54.5b | $58.3b | $72.4b | $72.3b | |
| Short-term borrowings and current maturities of long-term debt | — | — | — | $3.9b | $4.8b | $3.6b | $3.1b | $4.3b | $4.5b | $6.1b | |
| Liabilities, Current | $49.3b | $50.5b | $53.2b | $61.8b | $72.4b | $78.3b | $89.2b | $99.1b | $103.8b | $114.9b | |
| Total current liabilities | $49.3b | $50.5b | $53.2b | $61.8b | $72.4b | $78.3b | $89.2b | $99.1b | $103.8b | $114.9b | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | $3.4b | $3.3b | $2.8b | $3.0b | $3.6b | $2.4b | |
| Other Liabilities, Noncurrent | $2.3b | $5.6b | $5.7b | $10.1b | $12.3b | $11.8b | $12.8b | $14.5b | $15.9b | $18.2b | |
| Deferred Tax Liabilities, Net | $2.8b | $2.2b | $2.5b | $3.0b | $3.4b | $3.3b | $2.8b | $3.0b | $3.6b | $2.4b | |
| Liabilities | $82.6b | $87.0b | $96.0b | $111.7b | $126.8b | $135.7b | $159.4b | $174.8b | $195.7b | $207.9b | |
| Total liabilities | $82.6b | $87.0b | $96.0b | $111.7b | $126.8b | $135.7b | $159.4b | $174.8b | $195.7b | $207.9b | |
| Nonredeemable noncontrolling interests | ($97.0m) | $2.1b | $2.6b | $2.8b | $2.8b | $3.3b | $3.7b | $5.7b | $5.6b | $6.0b | |
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | $2.0b | $2.2b | $1.9b | $1.7b | $2.2b | $1.4b | $4.9b | $4.5b | $4.3b | $1.6b | |
| Redeemable noncontrolling interests | $2.0b | $2.2b | $1.9b | $1.7b | $2.2b | $1.4b | $4.9b | $4.5b | $4.3b | $1.6b | |
| Stockholders’ equity: | |||||||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($2.7b) | ($2.7b) | ($4.2b) | ($3.6b) | ($3.8b) | ($5.4b) | ($8.4b) | ($7.0b) | ($3.4b) | ($2.1b) | |
| Accumulated other comprehensive loss | ($2.7b) | ($2.7b) | ($4.2b) | ($3.6b) | ($3.8b) | ($5.4b) | ($8.4b) | ($7.0b) | ($3.4b) | ($2.1b) | |
| Additional Paid in Capital | $0 | $1.7b | $0 | $7.0m | $0 | $0 | — | — | $0 | $559.0m | |
| Common Stock, Value, Issued | $10.0m | $10.0m | $10.0m | $9.0m | $10.0m | $10.0m | $9.0m | $9.0m | $9.0m | $9.0m | |
| Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding | 10.0m | 10.0m | 10.0m | 9.0m | 10.0m | 10.0m | 9.0m | 9.0m | 9.0m | 9.0m | |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Retained Earnings (Accumulated Deficit) | $40.9b | $48.7b | $55.8b | $61.2b | $69.3b | $77.1b | $86.2b | $95.8b | $96.0b | $95.6b | |
| Stockholders' Equity Attributable to Noncontrolling Interest | ($97.0m) | $2.1b | $2.6b | $2.8b | $2.8b | $3.3b | $3.7b | $5.7b | $5.6b | $6.0b | |
| Liabilities and Equity | $122.8b | $139.1b | $152.2b | $173.9b | $197.3b | $212.2b | $245.7b | $273.7b | $298.3b | $309.6b | |
| Total liabilities and shareholders’ equity | $122.8b | $139.1b | $152.2b | $173.9b | $197.3b | $212.2b | $245.7b | $273.7b | $298.3b | $309.6b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.